PRM42 - COST MODEL OF SWITCHING FROM ENBREL TO ETANERCEPT BIOSIMILARS, FOR NON MEDICAL REASONS, IN RHEUMATOID ARTHRITIS PATIENTS IN SPAIN

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2165
https://www.valueinhealthjournal.com/article/S1098-3015(18)35467-6/fulltext
Title : PRM42 - COST MODEL OF SWITCHING FROM ENBREL TO ETANERCEPT BIOSIMILARS, FOR NON MEDICAL REASONS, IN RHEUMATOID ARTHRITIS PATIENTS IN SPAIN
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35467-6&doi=10.1016/j.jval.2018.09.2165
First page :
Section Title :
Open access? : No
Section Order : 1512
Categories :
Tags :
Regions :
ViH Article Tags :